Skip to content

13F-HR filed by SECTORAL ASSET MANAGEMENT INC

SECTORAL ASSET MANAGEMENT INC filed this 13F-HR for the quarter ended 2013-06-30, filed 2013-08-12, with 56 holding rows worth $3,381,742,000.

Accession
0001104659-13-062747
Filed
2013-08-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2013

A holdings report, 56 entries on the cover page, a total value of $3,381,742,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,381,742,000 with VALUE read as thousands by filing date, 13F file number 028-10653. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Vertex Pharmaceuticals Incorporated92532F100COM2,526,014$202,233,000thousands by filing date
INCYTE CORP COM45337C102Stock7,641,357$168,110,000thousands by filing date
Gilead Sciences,Inc.375558103COM2,930,957$150,270,000thousands by filing date
MYLAN INC628530107COM4,730,003$146,772,000thousands by filing date
ACTAVIS INC00507K103COM1,125,666$142,082,000thousands by filing date
MEDIVATION INC58501N101COM2,717,173$133,685,000thousands by filing date
THERAVANCE INC88338T104COMMON STOCK3,167,118$122,029,000thousands by filing date
Merck & Co.,Inc.58933Y105COM2,575,329$119,624,000thousands by filing date
Boston Scientific Corporation101137107COM12,864,121$119,250,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock1,758,637$118,180,000thousands by filing date
ONYX PHARMACEUTICALS INC683399109COM1,356,043$117,732,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM1,973,064$109,979,000thousands by filing date
IMMUNOGEN INC45253H101COMMON STOCK6,418,984$106,491,000thousands by filing date
ILLUMINA INC452327109COM1,338,389$100,165,000thousands by filing date
CELGENE CORP151020104COM793,936$92,875,000thousands by filing date
ARIAD PHARMACEUTICALS INC04033A100COM5,292,682$92,569,000thousands by filing date
Amgen Inc.031162100COM900,519$88,845,000thousands by filing date
ALIGN TECHNOLOGY INC COM016255101Stock2,385,406$88,355,000thousands by filing date
ALLERGAN INC018490102COM1,047,777$88,265,000thousands by filing date
PERRIGO CO PLC F714290103COM593,725$71,841,000thousands by filing date
Eli Lilly and Company532457108COM1,288,250$63,279,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock274,666$61,767,000thousands by filing date
BIOGEN INC COM09062X103Stock283,300$60,966,000thousands by filing date
HEARTWARE INTL INC422368100COM605,947$57,632,000thousands by filing date
VARIAN MED SYS INC92220P105COM844,345$56,951,000thousands by filing date
HOLOGIC INC436440101COM2,656,554$51,271,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK3,555,725$50,776,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK5,090,047$50,544,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM512,108$47,237,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO492,333$46,826,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM507,800$42,975,000thousands by filing date
PHARMACYCLICS INC716933106COM487,224$38,720,000thousands by filing date
DEXCOM INC COM252131107Stock1,623,049$36,437,000thousands by filing date
NPS PHARMACEUTICALS INC62936P103COM2,302,428$34,790,000thousands by filing date
COVIDIEN PLCG2554F113SHS472,532$29,694,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock1,134,038$27,863,000thousands by filing date
HALOZYME THERAPEUTICS INC COM40637H109Stock3,260,962$25,925,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock321,032$21,130,000thousands by filing date
SEQUENOM INC COM NEW817337405COM4,103,868$17,277,000thousands by filing date
DR REDDYS LABS LTD ADR256135203ADR438,440$16,582,000thousands by filing date
VIROPHARMA INC928241108COMMON STOCK559,724$16,036,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR407,749$15,984,000thousands by filing date
THORATEC CORP885175307COM470,118$14,719,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM212,700$14,247,000thousands by filing date
SEATTLE GENETICS INC812578102COM421,769$13,269,000thousands by filing date
SAGENT PHARMACEUTICALS INC786692103COM610,056$12,799,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM846,196$12,744,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM1,514,700$12,390,000thousands by filing date
FOREST LABS INC345838106COM283,075$11,606,000thousands by filing date
AKORN INC009728106COM792,782$10,718,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW1,817,529$10,542,000thousands by filing date
TORNIER NVN87237108COMMON STOCK-FO437,266$7,652,000thousands by filing date
ACCURAY INC DEL004397105COM1,137,768$6,531,000thousands by filing date
NOVO-NORDISK A S ADR670100205ADR16,801$2,604,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM86,100$1,292,000thousands by filing date
NOVARTIS AG SPONSORED ADR66987V109ADR8,700$615,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-13-062747this filing2013-08-12acceptance time not in the bulk data set